Annual PTAB Webinar Series: Examining the Latest Developments on the PTAB’s use of Discretionary Denials
This webinar will discuss the latest developments on the PTAB’s use of discretionary denials. We will cover the USPTO’s Request for Comments to enact rules outlined in its discretionary denial precedential decisions and the reaction from industry. We will also discuss recent cases involving discretionary denials in the pharmaceutical and technology spaces and how they might impact IPRs and litigation going forward.
Earn up to 1.0 Professional CLE for NJ/NY/PA
Gregory Morris is the Leader of Honigman's Life Sciences Intellectual Property Litigation Practice Group. He holds a Ph.D. in Organic Chemistry from Northwestern University. Gregory’s practice focuses on pharmaceutical, biotechnology, and medical device patent litigation. He has extensive experience representing top pharmaceutical clients on the brand-side in Hatch-Waxman litigation. Gregory also regularly litigates inter partes review (IPR) proceedings before the US Patent and Trademark Office (USPTO). He co-led a team of attorneys who represented a pharmaceutical company in the first-ever successful defense of an Orange Book-listed patent in an IPR review. [Read More]
Vikram Mathrani is an intellectual property litigator focusing his practice on patent litigation. He handles various technologies, including pharmaceuticals, biotechnology, medical devices, electronics, consumer products, software, and industrial products. [Read More]
Latifa H. Dabaja is an associate in our Intellectual Property Litigation Department. She focuses on a wide range of matters including patent, trademark, copyright, and trade dress matters. She has assisted in the litigation and prosecution of technologies and products in the pharmaceutical, automotive, mechanical, software, and consumer goods industries. [Read More]
Moderator Matthew Hartman, Counsel, Akin Gump, NJIPLA Chair, PTAB Committee
Thank You To Our Sponsor
GoToWebinar Note: Once you register, you will receive a GoToWebinar confirmation e-mail with a unique link to join the session. Click "Add to calendar" to ensure you don't miss the webinar.
Annual PTAB Webinar Series: Amending Patent Claims in PTAB Proceedings
The PTAB’s Motion to Amend Pilot Program was launched in March of 2019 and offered a more robust opportunity for amendment to patent owners during AIA trials. Sam and Theodoros will describe the mechanics associated with the motions to amend under the Pilot Program, including recent updates and examples. They will also discuss important strategic considerations for both petitioners and patent owners, such as protective orders, effects of joinder, effects on stays and intervening rights, and alternatives to motion to amend practice.
Yung-Hoon (Sam) Ha's practice focuses on post-grant proceedings before the PTAB, patent litigation, and advising clients on patent matters. He focuses his practice on materials related technology, such as microprocessor fabrication, carbon nanotubes, fullerenes, quantum dots, glasses, polymers, batteries, solar cells, solar concentrators, plasma sputtering, wafer manufacturing and razor blades. He has worked on numerous other technologies that include microprocessors, wireless communication devices, digital cameras, automated staining machines and tracer compounds.[Read More]
Dr. Theodoros Konstantakopoulos' practice focuses on counseling clients on intellectual property matters, patent litigation in district courts and the International Trade Commission, and post-grant proceedings at the United States Patent and Trademark Office. As a registered patent attorney, Dr. Konstantakopoulos has also advised clients in preparing and prosecuting U.S. and foreign patent applications and portfolio strategy. Further, he has conducted numerous due diligence investigations and drafted opinions of counsel. [Read More]
Annual PTAB Webinar Series: Strategies to Leverage Recent PTAB Precedential Decisions
In recent years, the Patent Trial and Appeal Board has seen a significant uptick in the number of decisions designated precedential or informative. This presentation highlights a number of those key decisions and focuses on tactical considerations to leverage them as part of a comprehensive litigation strategy.
Rubén Muñoz represents public and privately-held companies in patent and trade secret litigation involving a wide array of technologies, including medical devices, biotechnology, pharmaceuticals and electronics. He represents clients in federal and state courts, before the International Trade Commission and before the Patent Trial and Appeal Board (PTAB) of the United States Patent Office in inter partes review proceedings.[Read More]
Dr. Jonathan Underwood is experienced in all phases of patent infringement litigation, including ANDA litigation, at the trial and appellate level. He defends clients in patent infringement suits, and asserts clients’ patent rights. Jon also counsels clients on strategic IP decisions. Jon’s experience includes representing clients in litigation before the U.S.P.T.O. in inter partes review proceedings. [Read More]
Annual PTAB Webinar Series: The Impact of PTAB Proceedings on Bio/Pharma Litigation and Strategy
While AIA proceedings are a popular mechanism to challenge patents, their use and influence in the bio/pharma space has been different than in other technology areas. As these proceedings have matured and evolved over the years, their influence in the bio/pharma space has evolved as well. Join us as we discuss the following topics:
Earn up to 1.0 Professional CLE for NJ/NY/PA
Alison J. Baldwin is a partner with McDonnell Boehnen Hulbert & Berghoff LLP. Ms. Baldwin brings nearly two decades of experience to in the pharmaceutical and agricultural spaces to your intellectual property project. Her background in biotechnology and plant science allows her to have a unique understanding of the needs and challenges faced by the firm’s pharmaceutical, agriculture, food, cannabis and biofuel clients. Eat it, Drink it, Wear it, Smoke it, or Drive it – Ms. Baldwin has advised clients in that field. [Read More]
Annual PTAB Webinar Series: Supreme Court + Federal Circuit cases from 2020 that Impact PTAB Proceedings
Eldora L. Ellison, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. Eldora is a co-chair of the firm's Patent Office Litigation Practice. Over the course of her 26-year career, Eldora has gained extensive experience in inter partes patent matters, building on a strong foundation in patent prosecution. Her experience includes representing clients in over 70 inter partes review and post-grant review proceedings, more than 15 patent interferences, and in various patent reexaminations and district court litigations. For example, Eldora was lead counsel on behalf of patent owner ImmunoGen in Phigenix v. ImmunoGen, 845 F.3d 1168 (Fed. Cir. 2017), in which the Federal Circuit — for the first time since the Court’s inception — established the legal standard for demonstrating standing in an appeal from a final agency action. [Read More]
David H. Holman, Ph.D., is an director in Sterne Kessler's Biotechnology & Chemical and Trial & Appellate Practice Groups. David has extensive experience in inter partes review proceedings and in the preparation and prosecution of U.S. and foreign patent applications. His technical expertise is in the areas of immunology, microbiology, and molecular biology.[Read More]
NJIPLA is pleased to announce our
Hon. Jimmie V. Reyna
Circuit Judge, United States Court of Appeals for the Federal Circuit
We hope you can join us as we honor Judge Jimmie Reyna with the
Jefferson Medal at our annual gala to be held at a new location:
The American Beauty Ballroom in the newly constructed
Embassy Suites by Hilton in Berkeley Heights, NJ.
Early-Bird Registration ends April 30.
New this year, dinner wine service will be included in the reception and dinner rate.
*Table for 10 Reservation
A table has a total of 10 seats, which includes 1 seat reserved for an Honored Guest. NJIPLA does not guarantee an Honored Guest at each table. The Honored Guest may also bring a guest, and if so, NJIPLA will add a seat to your table at no additional cost. Your firm's 9 Guest Names for the table must be provided by April 30.
Hotel Sleeping Room Reservation
A special NJIPLA room rate of $149.00 for Friday night (excluding tax) has been established. This accommodation is offered on a first-come, first-served basis until April 30.
You may book online Embassy Suites or call 1-844-714-1511.
Group Code: NJI
Group Name: Jefferson Medal Dinner Room Block
NJIPLA is pleased to offer sponsorship opportunities for our 2021 Jefferson Medal Dinner. Benefits are recognition in our pre-event emails, logo and link on the NJIPLA website, includes a Congratulatory Notice, acknowledgement of sponsorship during the event welcome remarks, and much more.
Congratulatory Notice $400.00
Congratulatory artwork must be submitted to email@example.com no later than April 30, 2021. All submissions are subject to the review and approval of NJIPLA in its sole discretion.
Specification - Size: 6' W x 9' H, Color: Black/White only, Artwork Format: PDF. Limit 1 page per firm/company.
Content is limited to appropriate expression of honor to the Jefferson Medal award recipient:
Free self-parking. Park in the rear to easily access the main entrance to the Reception and American Beauty Ballroom (Level 2).
A free shuttle bus will be available to and from Embassy Suites and Berkeley Heights Train Station or Netherwood Train Station during the day of the dinner. When you arrive at the train station, please call the hotel's front desk (908) 897-1970.
Refund / Cancellation Policy
No refunds or cancellations after April 30, 2021. Dinner reservations are transferable.
New Jersey Intellectual Property Law Association (NJIPLA)c/o RRR Associations, LLC2125 Center Avenue, Suite 616, Fort Lee, NJ, 07024